| |
| |
|
| Insider
Information: |
Newhall Charles W III |
| Relationship: |
Director |
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
17 |
|
| Direct
Shares |
1,746,114 |
|
|
Indirect Shares
|
133,127,843 |
|
|
| Direct
Value |
$3,532,214 |
|
|
|
Indirect Value
|
$195,937,495 |
|
|
| Total
Shares |
134,873,957 |
|
|
| Total
Value |
$199,469,709 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -49.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Welltek Incorporated |
WTKND |
Former 10% Owner |
2004-05-06 |
1,149 |
2004-09-28 |
14,470 |
Premium* |
|
|
Aradigm Corp |
ARDM |
10% Owner |
2003-12-11 |
51 |
2004-02-20 |
0 |
Premium* |
|
|
FoxHollow Technologies |
FOXH |
Former 10% Owner |
2004-11-02 |
0 |
2004-11-02 |
1,804,462 |
Premium* |
|
|
DZS Inc |
DZSI |
10% Owner |
2005-02-10 |
0 |
2008-03-10 |
12,051,646 |
Premium* |
|
|
Occam Networks Inc |
OCNW |
Former 10% Owner |
2006-11-07 |
1,623,555 |
2006-04-07 |
0 |
Premium* |
|
|
Gyre Therapeutics |
GYRE |
10% Owner |
2006-04-12 |
0 |
2008-01-17 |
4,565,512 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2009-01-30 |
2,083,426 |
Premium* |
|
|
Vonage Holdings Corp |
VG |
10% Owner |
2006-05-30 |
0 |
2011-03-11 |
22,793 |
Premium* |
|
|
Innerworkings Inc |
INWK |
10% Owner |
2007-11-16 |
0 |
2012-03-28 |
15,000 |
Premium* |
|
|
Pharmos Corp |
PARS |
Director, 10% Owner |
|
0 |
2009-05-08 |
14,435,105 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
10% Owner |
2007-06-05 |
0 |
2012-03-07 |
4,584,311 |
Premium* |
|
|
Echo Global Logistics Inc |
ECHO |
10% Owner |
2012-02-28 |
95 |
2012-02-28 |
0 |
Premium* |
|
|
Financial Engines, Inc. |
FNGN |
10% Owner |
|
0 |
2010-08-30 |
3,481,941 |
Premium* |
|
|
Groupon, Inc. |
GRPN |
10% Owner |
|
0 |
2011-11-03 |
87,184,956 |
Premium* |
|
|
Hyperion Therapeutics Inc |
HPTX |
10% Owner |
|
0 |
2012-07-31 |
2,884,221 |
Premium* |
|
|
Supernus Pharmaceuticals Inc |
SUPN |
Director |
2024-02-23 |
120,975 |
2015-06-15 |
0 |
Premium* |
|
|
Vitae Pharmaceuticals, Inc |
VTAE |
Director |
2015-07-01 |
289 |
2015-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
182 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GYRE |
Gyre Therapeutics |
10% Owner |
– – • |
2007-02-06 |
4 |
OE |
$0.08 |
$75 |
I/I |
1,000 |
2,000 |
0 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-02-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
15,045,979 |
|
- |
|
| DZSI |
DZS Inc |
officerTitle |
– – • |
2007-03-01 |
4 |
B |
$1.17 |
$250,929 |
I/I |
214,800 |
4,617,543 |
1.5 |
- |
|
| DZSI |
DZS Inc |
officerTitle |
– – • |
2007-03-02 |
4 |
B |
$1.20 |
$258,533 |
I/I |
214,800 |
4,724,943 |
1.5 |
- |
|
| DZSI |
DZS Inc |
officerTitle |
– – • |
2007-03-05 |
4 |
B |
$1.18 |
$193,621 |
I/I |
164,700 |
4,807,293 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-03-06 |
4 |
B |
$1.19 |
$257,990 |
I/I |
216,000 |
4,915,293 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-03-07 |
4 |
B |
$1.23 |
$264,751 |
I/I |
216,000 |
5,023,293 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-05-17 |
4 |
B |
$1.25 |
$2,771 |
I/I |
2,217 |
5,024,401 |
1.42 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-05-18 |
4 |
B |
$1.25 |
$408,834 |
I/I |
327,067 |
5,187,934 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-05-24 |
4 |
B |
$1.30 |
$374,400 |
I/I |
288,000 |
5,331,934 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-05-25 |
4 |
B |
$1.30 |
$211,458 |
I/I |
162,660 |
5,413,264 |
1.5 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2007-06-05 |
4 |
A |
$0.00 |
$0 |
I/I |
4,472,224 |
821,736 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2007-06-05 |
4 |
S |
$15.00 |
$96,120 |
I/I |
(6,408) |
3,659,157 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2007-06-05 |
4 |
OE |
$6.38 |
$96,116 |
I/I |
15,077 |
3,665,565 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2007-07-25 |
4 |
A |
$11.49 |
$338,452 |
I/I |
29,447 |
851,183 |
0 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-07-27 |
4 |
B |
$1.13 |
$201,969 |
I/I |
179,400 |
5,502,964 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-07-30 |
4 |
B |
$1.17 |
$246,149 |
I/I |
210,600 |
5,608,264 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-07-31 |
4 |
B |
$1.19 |
$249,729 |
I/I |
210,600 |
5,713,564 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-08-01 |
4 |
B |
$1.18 |
$248,824 |
I/I |
210,600 |
5,818,864 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-08-02 |
4 |
B |
$1.20 |
$252,720 |
I/I |
210,600 |
5,924,164 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-08-03 |
4 |
B |
$1.16 |
$243,411 |
I/I |
210,600 |
6,029,464 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-08-06 |
4 |
B |
$1.10 |
$260,991 |
I/I |
238,000 |
6,148,464 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-08-07 |
4 |
B |
$1.11 |
$264,656 |
I/I |
238,000 |
6,267,464 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-08-08 |
4 |
B |
$1.13 |
$269,630 |
I/I |
238,000 |
6,386,464 |
1.5 |
- |
|
| DZSI |
DZS Inc |
10% Owner |
– – • |
2007-08-09 |
4 |
B |
$1.15 |
$184,550 |
I/I |
160,450 |
6,466,689 |
1.5 |
- |
|
182 Records found
|
|
Page 3 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
